Called ‘Supplement your Knowledge,’ the resource is broken down into four sections, each presented as an infographic of sorts, in downloadable PDF form. Regulation primer,
Tag: FDA
FDA Draft Guidance Seeks to Improve Safety Information on Dietary Supplements
Key Takeaways A new draft guidance from the FDA indicates that the agency may gather more safety information on dietary supplements. Manufacturers would be required
FDA, marketers of NAC may have motives to seek NAC rulemaking
A first-of-its-kind FDA rulemaking legalizing NAC (N-acetyl-L-cysteine) in dietary supplements could provide a “proof of concept that this authority works and that the agency can
FDA formally announces NAC enforcement discretion, but legal hangover remains
The NAC draft guidance issued today by FDA was seen as a victory for industry. But observers say it leaves central legal questions regarding the
FDA bioavailability guidance takes industry feedback into consideration
Posted 14 April 2022 | By Ferdous Al-Faruque Source: Anna Shvets/Pexels The US Food and Drug Administration (FDA) has published a final guidance on the
FDA denies NAC petitions, signals it won’t enforce
FDA on Thursday denied requests by two trade associations that the agency reverse its position that NAC (N-acetyl-L-cysteine) is excluded from the definition of a